MediWales

As the independent life science network for Wales, MediWales brings together industry, academia and the clinical community to support the advancement of human life science in Wales and create collaborations and business opportunities for our members

Deborah Laubach
Deborah Laubach
LinkedIn logo Operations Director 

Mironid

A bright future for patients with rare kidney disease Mironid® is developing novel small-molecule therapeutics that directly target the central signalling mechanism that drives ADPKD.

Neil Wilkie
CEO 

Nanovery

Our unique platform technology accurately quantifies nucleic acid sequences in your sample with a quick and simple workflow.

Using cutting-edge DNA nanotechnology, we build nanorobotic sensors tailored to your needs, enabling you to reach better outcomes at a fraction of the effort, cost and time.

Jerzy Kozyra
CEO 

NIHR Research Delivery Network

Our vision is for the UK to be a global leader in the delivery of high quality research that is inclusive, accessible, and improves health and care.

Our mission is to enable the health and care system to attract, optimise and deliver research across England.

We have two primary purposes:

  • support the successful delivery of high quality research, as an active partner in the research system
  • increase capacity and capability of the research delivery infrastructure for the future
Tracy Harman
Deputy Director of Strategic Development  
Emanuela Mariani
Business Development Manager 
Richard Brooks
Senior Business Development Manager 
Sajni Haria
Senior Business Development Manager 
Karen Matthews
Senior Business Development Manager  
William Rosenberg
Deputy Medical Director 
Lynsey Corless
Gastroenterology and hepatology specialist 

Pencil Biosciences

Pencil Biosciences is developing a truly innovative gene editing technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases The technology is small, modular in design, and non-CRISPR in composition.
Amanda Smith
LinkedIn logo CEO 

Pracipio

Anticipate, advise and advance - Pracipio helps you achieve your business objectives by applying a team of consultants who have formed a best in class management and strategy consultancy.

Fredrik Elg
Director 

Sareum

Sareum is a clinical-stage small molecule company actively involved in developing next-generation kinase inhibitors to treat autoimmune diseases and cancer.

We recognise the crucial role of the TYK/JAK kinase cell signalling family in maintaining a healthy immune system, and our pipeline is primarily focused on this area of scientific and commercial interest.

Tim Mitchell
COO 

Scancell

Scancell is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Mandeep Sehmi
Head of Business Development 

Simbec-Orion

We are Simbec-Orion, who for almost five decades, have been delivering clinical trial management services across a wide range of therapeutic indications and phases. A clinical research organisation with a flexible, specialist approach, we strive to become a trusted partner for our clients. Our passion as a CRO is rare diseases and oncology.

Cristian Ungureanu
Director of Business Development 
Delphine Gibus
Senior Director, Business Development 

Stablepharma

Stablepharma aims to ensure that all vaccines can be removed from the refrigerated cold chain and stored for months or even years at room temperature.

Karen O'Hanlon
LinkedIn logo Chief Development Officer 
Özgür Tuncer
LinkedIn logo CEO & Executive Director 
Kenny Simmen
LinkedIn logo Chief Business Officer